1. 31PTepotinib inhibits the epithelial-mesenchymal transition and tumour growth of gastric cancers via decreasing MUC5B, MMP7, and COX2. (7th November 2019) Authors: Zang, D Y; Sohn, S-H; Sul, H J; Kim, B; Choi, B Y; Kim, H S Journal: Annals of oncology Issue: Volume 30(2019)Supplement 7 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 678PTreatment patterns and changes in quality of life during first-line palliative chemotherapy in Korean patients with advanced gastric cancer. (23rd October 2018) Authors: Lee, K-W; Kim, J W; Kim, J G; Kang, B W; Chung, I J; Hong, Y S; Kim, T-Y; Lee, K H; Zang, D Y; Ko, Y H; Song, E-K; Baek, J H; Koo, D; Oh, S Y; Cho, H Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 680PA phase III study to compare the efficacy and safety of paclitaxel versus irinotecan in patients with metastatic or recurrent gastric cancer who failed in first-line therapy (KCSG ST10-01). (23rd October 2018) Authors: Lee, K-W; Maeng, C H; Kim, T-Y; Zang, D Y; Kim, Y H; Hwang, I G; Oh, S C; Chung, J S; Song, H S; Kim, J W; Jeong, S J; Cho, J Y Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗